Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)

Market Cap	6.25B +12.0%
Revenue (ttm)	2.93B -9.9%
Net Income	-100.35M
EPS	-0.07
Shares Out	1.37B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,424,600
Open	4.390
Previous Close	4.530
Day's Range	4.390 - 4.640
52-Week Range	4.080 - 6.940
Beta	0.29
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About SHE:002424

Guizhou Bailing Group Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells medicines in China. It operates through four segments: Industrial, Commerce, Medical institutions, and Others The company offers medicines in various forms, including tablets, capsules, granules, syrups, powders, pills, dews, pastes, sprays, and oral liquids, as well as wines and honey. Its products are used for cardiovascular, cough, cold, gynecological, and pediatric areas. The company was incorporated in 1999 and is headq...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 5,715
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002424

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 3, 2026

Data Sources Report a data error